InMed Pharmaceuticals Inc.
INM
$1.34
$0.021.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.21M | -8.16M | -8.31M | -7.91M | -6.82M |
| Total Depreciation and Amortization | 546.50K | 534.80K | 555.60K | 576.70K | 600.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 185.50K | 198.10K | 229.50K | 219.80K | 369.10K |
| Change in Net Operating Assets | -68.60K | -337.80K | 508.70K | -175.50K | -791.20K |
| Cash from Operations | -7.55M | -7.77M | -7.02M | -7.29M | -6.64M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -9.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | -9.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.13M | 13.16M | 4.36M | 1.43M | 6.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -829.30K | -883.90K | -264.50K | -249.40K | -754.00K |
| Cash from Financing | 11.30M | 12.27M | 4.10M | 1.18M | 5.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.75M | 4.50M | -2.92M | -6.12M | -1.16M |